Banco Bilbao Vizcaya Argentaria, S.A. Moderna, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $8.53 Billion
- Q3 2024
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 169,328 shares of MRNA stock, worth $7.11 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
169,328Holding current value
$7.11 Million% of portfolio
0.13%Shares
17 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.78 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.69 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.07 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$708 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$304 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...